Match tier Confirmed
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-10-10

Kieng B. Vang

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Research Assistant Professor

Also affiliated: University of Minnesota (2007–2018); University of Arkansas Medical Center (2023–2025); University of Arkansas System (2018–2020); Maastricht University Medical Centre (2011); Maastricht University (2011); CCS Associates (United States) (2023); Masonic Cancer Center (2010–2011)

17 h-index 44 pubs 1,631 cited

  • Animals
  • Mice
  • Humans
  • Cell Differentiation
  • T-Lymphocytes, Regulatory
  • Interleukin-2
  • Mice, Inbred C57BL
  • Signal Transduction
  • Dendritic Cells
  • Melanoma, Experimental
  • Cell Survival
  • Biocompatible Materials
  • Cytokines
  • STAT5 Transcription Factor
  • Mice, Knockout

Biography and Research Information

Metrics

  • h-index: 17
  • Publications: 44
  • Citations: 1,631

Positions

  • Research Assistant Professor 2015–present
    University of Arkansas at Little Rock Center for Integrative Nantechnology Sciences ORCID
  • Research Assistant Professor publications 2022–2025
    University of Arkansas for Medical Sciences ORCID

Selected Publications

  • Abstract 3844: Tumor endothelial cell lines and their use for the identification of new tumor vascular targets during dysbiosis (2025)
    Cancer Research DOI OpenAlex
  • Abstract 1088: Acquired radiation resistance induces thiol-dependent cisplatin cross-resistance (2023)
    Cancer Research 1 citation DOI OpenAlex
  • Supplemental Figures 1-9 and Table S1 from Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking (2023)
  • Supplemental Figures 1-9 and Table S1 from Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking (2023)
  • Abstract 3529: T-cell trafficking and extravasation is suppressed in distal tumors during gastrointestinal tract dysbiosis (2022)
    Cancer Research DOI OpenAlex
  • Cell-Biomaterial constructs for wound healing and skin regeneration (2022)
    Drug Metabolism Reviews 11 citations DOI OpenAlex
  • Gold nanorods enhance different immune cells and allow for efficient targeting of CD4+ Foxp3+ Tregulatory cells (2021)
    PLoS ONE 5 citations DOI OpenAlex
  • Dysbiotic stress increases the sensitivity of the tumor vasculature to radiotherapy and c-Met inhibitors (2021)
    Angiogenesis 4 citations DOI OpenAlex
  • Dendritic cell biocompatibility of ether‐based urethane films (2021)
    Journal of Applied Toxicology 4 citations DOI OpenAlex
  • Evidence for Early Stage Anti-Tumor Immunity Elicited by Spatially Fractionated Radiotherapy-Immunotherapy Combinations (2020)
    Radiation Research 67 citations DOI OpenAlex
  • Graphene-based 2D constructs for enhanced fibroblast support (2020)
    PLoS ONE 20 citations DOI OpenAlex
  • Abstract 2823: Sample storage conditions alter microbiome profiles - its potential relevance for cancer patients undergoing fecal microbial transplants (2019)
    Tumor Biology DOI OpenAlex
  • Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking (2019)
    Cancer Research 41 citations DOI OpenAlex
  • Abstract 2823: Sample storage conditions alter microbiome profiles - its potential relevance for cancer patients undergoing fecal microbial transplants (2019)
    Cancer Research DOI OpenAlex
  • Quantification of cellular associated graphene and induced surface receptor responses (2019)
    Nanoscale 10 citations DOI OpenAlex

View all publications on OpenAlex →